We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Troubling Lancet Trend Pushes FDA to Skip Draft Guidance
Troubling Lancet Trend Pushes FDA to Skip Draft Guidance
December 3, 2010
Citing an increasing trend of reusing blood lancets for multiple patients, the FDA has bypassed the draft guidance process to go straight to a final guidance on labeling for the fingerstick devices.